CTIS2023-505745-16-00招募中1 期
A study to evaluate the safety, tolerance and changes in blood levels of an anti-toxin drug (FBT-002) in healthy male and female subjects
Eurofins Optimed0 个研究点目标入组 24 人开始时间: 2023年10月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A study to investigate the safety, tolerability and absorption and elimination of CCX507-B, a new drug for the treatment of patients with inflammatory bowel diseases, in healthy male and female subjects.Crohn's disease.Inflammatory bowel diseases10017969NL-OMON40895ChemoCentryx, Inc.30
已完成
不适用
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Donepezil with Glycopyrrolate or Trospium in Elderly Volunteers1004225810012272Alzheimer's diseasedementiaNL-OMON45462Axovant Sciences Ltd.75
已完成
1 期
A programme to develop a skin patch containing two medicines (physostigmine and hyoscine), Study 6: Assessment of blood levels of the two medicines and any associated symptoms in healthy female participants.ISRCTN15358284Dstl36
招募中
1 期
The effect of empagliflozin on proteinuriaIRCT20220405054414N1Iran University of Medical Sciences15
进行中（未招募）
不适用
A study investigating the safety, tolerability and pharmacodynamics of bacterial lipase in patients with cystic fibrosis and pancreatic insufficiencyRandomized, double-blind, placebo-controlled, single period, parallel group desigEUCTR2006-005180-25-DEordmark Arzneimittel GmbH20